series

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

1. 59/100

   Safety of lecanemab in real-world patients with Alzheimer's disease: a prospective, observational case series supported by FAERS signal analysis

   ✓ Peer-reviewed alzhub usefulness score 59 out of 100. Frontiers in neuroinformatics · 2026-10-02 · Treatments

   Although clinical trials have demonstrated its favorable safety profile, real-world studies are crucial for identifying rare adverse events (AEs) and evaluating post-marketing safety.

   • Treatments
   • Side Effects
2. 55/100

   Spectrum of amyloid-related imaging abnormalities associated with aducanumab treatment: a case series report

   ✓ Peer-reviewed alzhub usefulness score 55 out of 100. BMC neurology · 2026-07-30 · Treatments

   These illustrative cases provide learnings into the nature and factors associated with ARIA that can increase knowledge for clinicians and trialists regarding the varied radiographic and clinical presentations and evolution of ARIA.

   • Treatments
   • Side Effects
   • Brain Scans
3. 48/100

   Genetic screen in a large series of patients with primary progressive aphasia

   ✓ Peer-reviewed alzhub usefulness score 48 out of 100. Alzheimer's & dementia : the journal of the Alzheimer's Association · 2019-01-25 · TREM2 and immune genetics

   Our results show that while pathogenic variants within the most common dementia genes were rarely associated with PPA, these were found almost exclusively in GRN and C9orf72, suggesting that PPA is more TDP43- than tau-related in our series.

   • Genetics
   • Other Dementias

All topic tags with their study counts